Viewing Study NCT04269551


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-02-17 @ 6:47 PM
Study NCT ID: NCT04269551
Status: COMPLETED
Last Update Posted: 2025-09-22
First Post: 2020-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease
Sponsor: Bioverativ, a Sanofi company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autoimmune Haemolytic Anaemia View
Keywords: